ARVN vs. KYMR
Compare and contrast key facts about Arvinas, Inc. (ARVN) and Kymera Therapeutics, Inc. (KYMR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARVN or KYMR.
Key characteristics
| ARVN | KYMR | |
|---|---|---|
| YTD Return | -15.21% | 34.92% |
| 1Y Return | 22.28% | -1.41% |
| 3Y Return (Ann) | -18.71% | -3.27% |
| Sharpe Ratio | 0.41 | 0.02 |
| Daily Std Dev | 71.55% | 70.49% |
| Max Drawdown | -86.85% | -87.51% |
| Current Drawdown | -67.65% | -60.89% |
Fundamentals
| ARVN | KYMR | |
|---|---|---|
| Market Cap | $2.37B | $2.08B |
| EPS | -$6.62 | -$2.52 |
| Revenue (TTM) | $78.50M | $78.59M |
| Gross Profit (TTM) | $131.40M | -$117.42M |
| EBITDA (TTM) | -$396.70M | -$163.46M |
Correlation
The correlation between ARVN and KYMR is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ARVN vs. KYMR - Performance Comparison
In the year-to-date period, ARVN achieves a -15.21% return, which is significantly lower than KYMR's 34.92% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARVN vs. KYMR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arvinas, Inc. (ARVN) and Kymera Therapeutics, Inc. (KYMR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARVN vs. KYMR - Dividend Comparison
Neither ARVN nor KYMR has paid dividends to shareholders.
Drawdowns
ARVN vs. KYMR - Drawdown Comparison
The maximum ARVN drawdown since its inception was -86.85%, roughly equal to the maximum KYMR drawdown of -87.51%. Use the drawdown chart below to compare losses from any high point for ARVN and KYMR. For additional features, visit the drawdowns tool.
Volatility
ARVN vs. KYMR - Volatility Comparison
The current volatility for Arvinas, Inc. (ARVN) is 9.56%, while Kymera Therapeutics, Inc. (KYMR) has a volatility of 13.36%. This indicates that ARVN experiences smaller price fluctuations and is considered to be less risky than KYMR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ARVN vs. KYMR - Financials Comparison
This section allows you to compare key financial metrics between Arvinas, Inc. and Kymera Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities